Mutagenicity of Hypericum lysimachioides extracts

References

• Adam W, Hauer H, Mosandl T, Saha-Möller CR, Wagner W, Wild D (1990): Furocoumarin, naphthofuran and furoquinoline, annulated 1,2-dioxetanes: Synthesis, thermolysis, and mutagenicity. Liebigs Annalen der Chemie 12: 1227–1236.
   Google Scholar
• Ames BN, Lee FD, Durston W (1973): An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Natl Acad Sci USA 70: 782–786.
   PubMed Web of Science ®Google Scholar
• Aruoma OI (1994): Nutrition and health aspects of free radicals and antioxidants. Food Chem Toxicol 32: 671–683.
   PubMed Web of Science ®Google Scholar
• Baytop T (1984): Therapy with Medicinal Plants in Turkey. Istanbul University Press, pp. 185–186.
   Google Scholar
• Bjeldanesi LF, Chang GW (1997): Mutagenic activity of quercetin and related compounds. Science 197: 577–578.
   Google Scholar
• Chung MI, Weng JR, Lai MH, Yen MH, Lin CN (1999): A new chalcone, xanthones and xanthonolignoid from Hypericum geminiflorum. J Nat Prod 62: 1033–1035.
   PubMed Web of Science ®Google Scholar
• Constantine GH, Karchesy J (1998): Variations in hypericin concentration in Hypericum perforatum and commerical products. Pharm Biol 36: 365–367.
   Web of Science ®Google Scholar
• Daferera DJ, Ziogas BN, Polissiou MG (2003): The effectiveness of plant essential oils on the growth of Botrytis cinerea, Fusarium sp. and Clavibacter michiganensis subsp. michi-ganensis. Crop Protect 22: 39–44.
   Web of Science ®Google Scholar
• De Flora S, Izzotti A, Randerath K, Randerath E, Bartsch H, Nair J, Balansky R, van Schooten FJ, Degan P, Fronza G, Walsh D, Lewtas J (1996): DNA adducts in chronic degenerative diseases. Pathogenic relevance and implications in preventive medicine. Mutat Res 366: 197–238.
   PubMed Web of Science ®Google Scholar
• Decosterd LA, Hoffmann E, Kybruz R, Bray D, Hostettmann K (1991): A new phloroglucinol derivative from Hypericum calycinum with antifungal and in vitro antimalarial activity. Planta Med 57: 548–551.
   PubMed Web of Science ®Google Scholar
• Elgorashi EE, Taylor JLS, Maes A, De Kimpe N, van Staden J, Verschaeve L (2002): The use of plants in traditional medicine: Potential genotoxic risks. S Afr J Bot 68: 408–410.
   Web of Science ®Google Scholar
• Ferraz BFA, Bordignon ALS, Staats C, Schripsema J, Von Poser GL (2001): Benzopyrans from Hypericum polyanthemum. Phytochemistry 57: 1227–1230.
   PubMedGoogle Scholar
• Hakimoglu F, Kızıl G, Kanay Z, Kızıl M, Issı H (2007): The effect of ethanol extract of Hypericum lysimachioides on lipid profile in hypercholesterolemic rabbits and its in vitro antioxidant activity. Atherosclerosis 192: 113–122.
   PubMed Web of Science ®Google Scholar
• Isman MB, Wan AJ, Passreiter CM (2001): Insecticidal activity of essential oils to the tobacco cutworm Spodoptera litura. Fitoterapia 72: 65–68.
   PubMed Web of Science ®Google Scholar
• Kamuhabwa AR, Agostinis P, Kasran A, De Witte PA (2000): Photodynamic activity of hypericin in human urinary bladder carcinoma cell. Anticancer Res 20: 2579–2584.
   PubMedGoogle Scholar
• Kikuchi T, Kadota S, Matsuda S, Tanaka K, Namba T (1985): Studies on the constituents of medicinal and related plants in Sri Lanka. Isolation and structure of new γ-pyrone and related coumponds from Hypericum mysorense Heyne. Chem Pharm Bull 33: 557–564.
   PubMed Web of Science ®Google Scholar
• Kızıl G, Kızıl M, Yavuz M, Emen S, Hakimoğlu F (2008): Antioxidant activities of ethanol extracts of Hypericum triquetrifolium and Hypericum scabroides. Pharm Biol 46: 231–242.
   Web of Science ®Google Scholar
• Levin DE, Yamasaki E, Ames BN (1982): Salmonella tester strain, TA97 for the detection of frameshift mutagens. A run of cytosines as a mutational hot-spot. Mutat Res 94: 315–330.
   PubMed Web of Science ®Google Scholar
• Maron DM, Ames BN (1983): Revised methods for the Salmonella mutagenicity test. Mutat Res 113: 173–215.
   PubMed Web of Science ®Google Scholar
• Marzin DR, Olivier P, Vophi H (1986): Kinetic determination of enzymatic activity and modification of the metabolic activation system in the SOS chromotest. Mutat Res 164: 353–359.
   PubMedGoogle Scholar
• Meruelo D, Lavie G, Lavie D (1988): Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: Aromatic polycyclic dions hypericin and pseudohypericin. Proc Natl Acad Sci USA 85: 5230–5234.
   PubMed Web of Science ®Google Scholar
• Mu Q, Gibbons S, Stavri M, Smith E, Zhou FS, HU CQ (2006): Antibacterial effects of Hypericum ascyron and Hypericum japonicum against multidrug-resistant Staphylococcus aureus. Pharm Biol 44: 157–159.
   Web of Science ®Google Scholar
• Nagao M, Morita N, Yahagi T, Mineo S, Masanori K, Masamichi F, Kunitoshi Y, Shinsaku N, Tadahiko F, Takashi S (1981): Mutagenicities of 61 flavonoids and 11 related compounds. Environ Mutagen 3: 401–419.
   PubMedGoogle Scholar
• OECD (1977): Organisation for Economic Co-Orperation and Development (OECD) Guidelines for the Testing of Chemicals, Section 4: Healthy Effects, Test No. 471: Bacterial Reverse Mutation Tests. Paris, OECD, pp. 1–11.
   Google Scholar
• Ogawa S, Hirayama T, Fujioka Y, Ozasa S, Tokuda M, Hirai K, Fukui S (1987): Mutagenicity modulating effect of quercetin on aromatic amines and acetamides. Mutat Res 192: 37–46.
   PubMedGoogle Scholar
• Okpanyi SN, Schirpke-von Paczensky R, Dickson D (1989): Anti-inflammatory, analgesic and antipyretic effect of various plant extracts and their combinations in an animal model. Arzneimittelforschung 39: 698–703.
   PubMed Web of Science ®Google Scholar
• Okpanyi SN, Lidzba H, Scholl BC, Miltenburger HG (1990): Genotoxicity of a standardized Hypericum extract. Arzneimittelforschung 40: 851–855.
   PubMedGoogle Scholar
• Popat A, Shear NH, Malkiewicz I, Stewart MJ, Steenkamp V, Thomson S, Neuman MG (2001): The toxicity of Callilepis laureola, a South African traditional herbal medicine. Clin Biochem 34: 229–236.
   PubMed Web of Science ®Google Scholar
• Quillardet P, Hofnung M (1985): The SOS chromotest, a colorimetric bacterial assay for genotoxins: Precedures. Mutat Res 147: 65–78.
   PubMed Web of Science ®Google Scholar
• Robson NKB (1975): Flora of Turkey and the East Aegean Islands, PH Davis, editor. Edinburgh, Edinburgh University Press, pp. 355–401.
   Google Scholar
• Saya O, Selcuk AE, Ozen HC, Hosgoren H, Toker Z (2001): Medicinal Plants of GAP area. Ankara, Environment Foundation of Turkey, pp. 143–144.
   Google Scholar
• Schmitt LA, Liu Y, Murphy PA, Birt DF (2006) Evaluation of the light-sensitive cytotoxicity of Hypericum perforatum extracts, fractions, and pure compounds. J Agric Food Chem 54: 2881–2890.
   PubMed Web of Science ®Google Scholar
• Simoes CMO, Sckenkel EP, Gosmann G, Mello JCP, Mentz LA, Petrovick PR (1999): Farmacognosia: da planta ao medicamento. Porto Alegre/Florianopolis, Universidade/UFRGS/UFSC, p. 821.
   Google Scholar
• Takahashi I, Nakanishi S, Kobayashi E, Nakano H, Suziki K, Tamaoki T (1989): Hypericin and pseudohypericin specifically inhibit protein kinase c: Possible relation to their antiretroviral activity. Biochem Biophys Res Commun 165: 1207–1212.
   PubMed Web of Science ®Google Scholar
• Toker Z, Kızıl G, Özen Hç, Kızıl M, Ertekin AS (2006): Composition and antimicrobial activities of the essential oils of two Hypericum species from Turkey. Fitoterapia 77: 57–60.
   PubMed Web of Science ®Google Scholar
• Trifuniviç S, Vajs V, Macura S, Juraniç N, Djarmati Z, Jankov R, Mılasavljeviç S (1998): Oxidation products of hyperforin from Hypericum perforatum. Phytochemistry 49: 1305–1310.
   PubMedGoogle Scholar
• Umek A, Kreft S, Kartnig T, Heydel B (1999): Quantitive phytochemical analyses of six Hypericum species growing in Slovenia. Planta Med 65: 388–390.
   PubMed Web of Science ®Google Scholar
• Vandenbogaerde A, Witte P (1995): Antineoplastic properties of photosensitized hypericin. Anticancer Res 15: 1757–1758.
   Google Scholar
• Verotta L, Appendino G, Jakupoviç J, Bombardelli E (2000): Hyperforin analogues from St John’s wort, J Nat Prod 63: 412–415.
   PubMed Web of Science ®Google Scholar
• Zeiger E (2001): Mutagens that are not carcinogenic: Faulty theory or faulty tests? Mutat Res 492:29–38.
   PubMed Web of Science ®Google Scholar